Theratechnologies Inc. (TH.TO)
CAD 3.53
(1.44%)
CAD 3.53
(1.44%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -10.62 Million USD | 73.37% |
| 2022 | -39.9 Million USD | -58.14% |
| 2021 | -25.23 Million USD | -40.54% |
| 2020 | -17.95 Million USD | -140.87% |
| 2019 | -7.45 Million USD | -118.27% |
| 2018 | -3.41 Million USD | 60.39% |
| 2017 | -8.62 Million USD | -394.22% |
| 2016 | 2.93 Million USD | -5.45% |
| 2015 | 3.09 Million USD | 127.59% |
| 2014 | -11.23 Million USD | -166.07% |
| 2013 | -4.22 Million USD | 71.75% |
| 2012 | -14.94 Million USD | 17.77% |
| 2011 | -18.17 Million USD | -378.11% |
| 2010 | 6.53 Million USD | 145.91% |
| 2009 | -14.23 Million USD | 63.45% |
| 2008 | -38.95 Million USD | -3.84% |
| 2007 | -37.51 Million USD | -65.58% |
| 2006 | -22.65 Million USD | -428.04% |
| 2005 | -4.29 Million USD | 77.72% |
| 2004 | -19.26 Million USD | 40.06% |
| 2003 | -32.13 Million USD | -104.82% |
| 2002 | -15.68 Million USD | -78.23% |
| 2001 | -8.8 Million USD | -37.12% |
| 2000 | -6.41 Million USD | -60.23% |
| 1999 | -4 Million USD | -6.11% |
| 1998 | -3.77 Million USD | 14.71% |
| 1997 | -4.42 Million USD | -12.56% |
| 1996 | -3.93 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 3.28 Million USD | 246.39% |
| 2024 Q1 | -2.24 Million USD | -184.12% |
| 2024 Q3 | 6.21 Million USD | 88.96% |
| 2023 FY | -10.62 Million USD | 73.37% |
| 2023 Q4 | 2.67 Million USD | 4844.44% |
| 2023 Q2 | -7.94 Million USD | -46.92% |
| 2023 Q1 | -5.4 Million USD | 5.27% |
| 2023 Q3 | 54 Thousand USD | 100.68% |
| 2022 Q4 | -5.7 Million USD | -3.42% |
| 2022 Q3 | -5.51 Million USD | 73.67% |
| 2022 Q2 | -20.96 Million USD | -171.52% |
| 2022 FY | -39.9 Million USD | -58.14% |
| 2022 Q1 | -7.72 Million USD | 4.28% |
| 2021 Q3 | -7.23 Million USD | -35.32% |
| 2021 FY | -25.23 Million USD | -40.54% |
| 2021 Q4 | -8.06 Million USD | -11.43% |
| 2021 Q1 | -4.58 Million USD | -11.56% |
| 2021 Q2 | -5.34 Million USD | -16.69% |
| 2020 Q2 | -4.48 Million USD | -32.28% |
| 2020 Q1 | -3.39 Million USD | 37.15% |
| 2020 FY | -17.95 Million USD | -140.87% |
| 2020 Q4 | -4.1 Million USD | 31.16% |
| 2020 Q3 | -5.96 Million USD | -33.03% |
| 2019 Q4 | -5.39 Million USD | -744.6% |
| 2019 Q2 | -2.01 Million USD | -338.48% |
| 2019 Q1 | -460 Thousand USD | -429.92% |
| 2019 FY | -7.45 Million USD | -118.27% |
| 2019 Q3 | -639 Thousand USD | 68.32% |
| 2018 Q4 | 139.42 Thousand USD | 69.24% |
| 2018 FY | -3.41 Million USD | 60.39% |
| 2018 Q1 | -1.98 Million USD | 26.09% |
| 2018 Q2 | -1.69 Million USD | 14.23% |
| 2018 Q3 | 82.38 Thousand USD | 104.85% |
| 2017 Q1 | -27.29 Thousand USD | -101.79% |
| 2017 FY | -8.62 Million USD | -394.22% |
| 2017 Q4 | -2.68 Million USD | -16.84% |
| 2017 Q3 | -2.29 Million USD | 32.32% |
| 2017 Q2 | -3.39 Million USD | -12324.31% |
| 2016 FY | 2.93 Million USD | -5.45% |
| 2016 Q1 | 371.92 Thousand USD | -64.28% |
| 2016 Q2 | 608.77 Thousand USD | 63.68% |
| 2016 Q3 | 417.08 Thousand USD | -31.49% |
| 2016 Q4 | 1.52 Million USD | 265.01% |
| 2015 Q2 | 1.14 Million CAD | 297.47% |
| 2015 Q1 | -580.25 Thousand USD | 57.38% |
| 2015 Q4 | 1.04 Million USD | -32.0% |
| 2015 FY | 3.09 Million USD | 127.59% |
| 2015 Q3 | 1.53 Million USD | 33.66% |
| 2014 FY | -11.23 Million USD | -166.07% |
| 2014 Q4 | -1.36 Million USD | 61.83% |
| 2014 Q3 | -3.56 Million USD | -18.71% |
| 2014 Q2 | -3 Million USD | 7.09% |
| 2014 Q1 | -3.23 Million USD | -27.8% |
| 2013 FY | -4.22 Million USD | 71.75% |
| 2013 Q2 | -1.45 Million USD | -185.63% |
| 2013 Q4 | -2.53 Million USD | -31.79% |
| 2013 Q1 | 1.69 Million USD | 137.41% |
| 2013 Q3 | -1.91 Million USD | -31.92% |
| 2012 Q4 | -4.54 Million USD | -403.52% |
| 2012 FY | -14.94 Million USD | 17.77% |
| 2012 Q3 | -902.27 Thousand USD | 42.32% |
| 2012 Q2 | -1.56 Million USD | 80.12% |
| 2012 Q1 | -7.86 Million USD | -692.46% |
| 2011 Q3 | -4.74 Million USD | 27.76% |
| 2011 Q2 | -6.56 Million USD | -11.46% |
| 2011 Q1 | -5.89 Million USD | -130.01% |
| 2011 FY | -18.17 Million USD | -378.11% |
| 2011 Q4 | -992.78 Thousand USD | 79.07% |
| 2010 Q4 | 19.63 Million USD | 660.86% |
| 2010 Q3 | -3.5 Million USD | 28.77% |
| 2010 Q2 | -4.91 Million USD | -21.05% |
| 2010 Q1 | -4.05 Million USD | 15.03% |
| 2010 FY | 6.53 Million USD | 145.91% |
| 2009 Q3 | 5.31 Million USD | 206.74% |
| 2009 Q2 | -4.98 Million USD | 41.19% |
| 2009 FY | -14.23 Million USD | 63.45% |
| 2009 Q4 | -4.77 Million USD | -189.85% |
| 2009 Q1 | -8.47 Million USD | -14.39% |
| 2008 Q4 | -7.4 Million CAD | 29.92% |
| 2008 Q2 | -11.46 Million CAD | -3.21% |
| 2008 Q1 | -11.11 Million CAD | 1.97% |
| 2008 FY | -38.95 Million USD | -3.84% |
| 2008 Q3 | -10.56 Million CAD | 7.87% |
| 2007 Q4 | -11.33 Million CAD | -17.8% |
| 2007 Q2 | -7.52 Million CAD | 6.63% |
| 2007 FY | -37.51 Million USD | -65.58% |
| 2007 Q1 | -8.06 Million CAD | -45.56% |
| 2007 Q3 | -9.62 Million CAD | -27.79% |
| 2006 Q3 | -6.55 Million CAD | -16.1% |
| 2006 FY | -22.65 Million USD | -428.04% |
| 2006 Q1 | -4.78 Million CAD | -0.37% |
| 2006 Q2 | -5.65 Million CAD | -18.03% |
| 2006 Q4 | -5.54 Million CAD | 15.54% |
| 2005 FY | -4.29 Million USD | 77.72% |
| 2005 Q4 | -4.76 Million CAD | -11.85% |
| 2005 Q3 | -4.26 Million USD | -6.17% |
| 2005 Q2 | -4.01 Million CAD | -147.57% |
| 2005 Q1 | 8.44 Million CAD | 256.8% |
| 2004 FY | -19.26 Million USD | 40.06% |
| 2004 Q4 | -5.38 Million CAD | -64.81% |
| 2004 Q3 | -3.26 Million USD | 39.99% |
| 2004 Q1 | -5.31 Million CAD | 69.52% |
| 2004 Q2 | -5.44 Million CAD | -2.41% |
| 2003 FY | -32.13 Million USD | -104.82% |
| 2003 Q4 | -17.44 Million CAD | -244.9% |
| 2003 Q3 | -5.05 Million CAD | 21.16% |
| 2003 Q2 | -6.41 Million CAD | -51.5% |
| 2003 Q1 | -4.23 Million CAD | 22.77% |
| 2002 Q1 | -4.88 Million CAD | -521.39% |
| 2002 Q3 | -4 Million CAD | 4.22% |
| 2002 Q4 | -5.48 Million CAD | -36.93% |
| 2002 FY | -15.68 Million USD | -78.23% |
| 2002 Q2 | -4.17 Million CAD | 14.43% |
| 2001 FY | -8.8 Million USD | -37.12% |
| 2001 Q4 | -786.02 Thousand CAD | 75.72% |
| 2001 Q3 | -3.23 Million CAD | -34.5% |
| 2001 Q2 | -2.4 Million CAD | -4.37% |
| 2001 Q1 | -2.3 Million CAD | -14.91% |
| 2000 FY | -6.41 Million USD | -60.23% |
| 2000 Q1 | -1.3 Million CAD | 1.57% |
| 2000 Q2 | -1.66 Million USD | -27.43% |
| 2000 Q3 | -1.36 Million USD | 18.09% |
| 2000 Q4 | -2 Million CAD | -46.81% |
| 1999 Q4 | -1.33 Million USD | -32.55% |
| 1999 Q2 | -1.08 Million USD | -36.41% |
| 1999 Q1 | -795.49 Thousand USD | -17.75% |
| 1999 FY | -4 Million USD | -6.11% |
| 1999 Q3 | -1 Million USD | 7.51% |
| 1998 FY | -3.77 Million USD | 14.71% |
| 1998 Q4 | -675.56 Thousand USD | 37.2% |
| 1998 Q1 | -1.12 Million USD | -35.85% |
| 1998 Q3 | -1.07 Million USD | 12.95% |
| 1998 Q2 | -1.23 Million USD | -9.92% |
| 1997 Q1 | -1.02 Million USD | 0.0% |
| 1997 FY | -4.42 Million USD | -12.56% |
| 1997 Q2 | -1.37 Million USD | -34.77% |
| 1997 Q3 | -1.07 Million USD | 21.67% |
| 1997 Q4 | -827.55 Thousand USD | 23.37% |
| 1996 FY | -3.93 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aurora Cannabis Inc. | -46.45 Million CAD | 77.123% |
| Avicanna Inc. | -7.93 Million CAD | -33.959% |
| Avant Brands Inc. | -1.45 Million CAD | -632.391% |
| Cardiol Therapeutics Inc. | -29.78 Million CAD | 64.322% |
| Crescita Therapeutics Inc. | -1.95 Million CAD | -443.303% |
| Knight Therapeutics Inc. | -2.89 Million CAD | -267.716% |
| MediPharm Labs Corp. | -18.25 Million CAD | 41.776% |
| OrganiGram Holdings Inc. | -242.73 Million CAD | 95.622% |
| Canopy Growth Corporation | -228.71 Million CAD | 95.354% |
| Willow Biosciences Inc. | -13.18 Million CAD | 19.382% |
| Auxly Cannabis Group Inc. | -19 Million CAD | 44.083% |